524650
PBS Tablets
10 mM phosphate buffer, and 3 mM KCl, tablet, pH 7.4 at 25°C
Synonym(s):
PBS, Phosphate Buffered Saline Tablets
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12161706
NACRES:
NA.25
Product Name
PBS Tablets, Dissolving one tablet of PBS buffer in 1 liter of deionized H2O yields 140 mM NaCl, 10 mM phosphate buffer, and 3 mM KCl, pH 7.4 at 25°C. Note: 1 each = 10 tablets.
Quality Level
form
tablet
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
shipped in
ambient
storage temp.
10-30°C
General description
Developed for use in immunoassay applications. Dissolving one tablet in 1 liter of deionized H2O yields 140 mM NaCl, 10 mM phosphate buffer, and 3 mM KCl, pH 7.4 at 25°C. Note: 1 each = 10 tablets.
Dissolving one tablet in 1 liter of deionized H2O yields 140 mM NaCl, 10 mM phosphate buffer, and 3 mM KCl, pH 7.4 at 25°C. Note: 1 each = 10 tablets.
Application
PBS Tablets have been used:
- as a wash buffer and as a blocking agent during immunohistochemical staining
- in indirect enzyme-linked immunosorbent assay (ELISA)and enzymatic degradation of polyethylene glycol (PEG)ylated fibrin hydrogels
Preparation Note
Dissolve one tablet in one liter dH₂O to yield 10 mM phosphate buffer, pH 7.4, 140 mM NaCl, 3 mM KCl.
Following reconstitution, store in the refrigerator (4°C) or filter sterilize and store at room temperature (20°C).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Irritant (B)
Still not finding the right product?
Explore all of our products under PBS Tablets
Storage Class
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Valentina Agnolon et al.
Scientific reports, 10(1), 3016-3016 (2020-02-23)
Circulating HER2 extracellular domain (HER2 ECD) levels were proposed as a surrogate for HER2 tissue expression to monitor breast cancer patients for early relapse or responses to standard or HER2-targeted therapies, such as the monoclonal antibody (mAb) trastuzumab. Currently, available commercial